Tue 4/24/2018 08:46 ET
DJIA24448.6914.250.06%SOLAR25.140.160.64%GOLD1314.203.550.27%Shanghai3128.9362.271.99%
S&P 5002670.290.000.00%BANKS27.850.030.11%OIL62.241.051.69%BITCOIN9344.67392.484.20%
NASDAQ7128.6017.820.25%SEMI97.691.281.31%US/EU1.220.000.05%Futures2686.7515.500.58%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Aviron - AVIR   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add AVIR
  
From: Mores (Rep: 3)Date: 01/12/2018 13:40
Forum: Aviron - Msg #137Thread #673982117 (Rec: 0)
The transaction maximizes the value of Aviragen: Based on the valuations of a selected set of publicly traded vaccine companies, Vaxart’s estimated potential valuation prior to the merger is approximately $158 million. Based on the ownership structure in the transaction, this would imply a value of the combined company at $264 million, with the potential value of Aviragen in the merger being $106 million, a significant improvement in value compared to Aviragen’s current market capitalization of approximately $23 millioni.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Mores: Reward | Watch | IgnoreAVIR: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add AVIR
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.